The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Steatorrhea

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Steatorrhea

 

High impact information on Steatorrhea

  • The runting syndrome consisted of retarded growth, oily hair, alopecia, and steatorrhea [6].
  • Colipase and maximally activated pancreatic lipase in normal subjects and patients with steatorrhea [7].
  • Daily stool weights increased significantly in three of four patients, though none had steatorrhea; there was a significant reduction in excretion of secondary bile acids; neutral sterol degradation rates were not affected by the drug [8].
  • CONCLUSIONS: Bacterial lipolytic activity should survive better within the gastrointestinal lumen than porcine lipolytic activity and be more effective to treat steatorrhea [9].
  • Steatorrhea and low lactase activities were found in more than 85% of the patients [10].
 

Chemical compound and disease context of Steatorrhea

 

Biological context of Steatorrhea

 

Anatomical context of Steatorrhea

 

Gene context of Steatorrhea

 

Analytical, diagnostic and therapeutic context of Steatorrhea

References

  1. The prevalence of occult gastrointestinal bleeding in celiac sprue. Fine, K.D. N. Engl. J. Med. (1996) [Pubmed]
  2. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis. Boyle, B.J., Long, W.B., Balistreri, W.F., Widzer, S.J., Huang, N. Gastroenterology (1980) [Pubmed]
  3. Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gaskin, K.J., Durie, P.R., Lee, L., Hill, R., Forstner, G.G. Gastroenterology (1984) [Pubmed]
  4. Cimetidine. H2-receptor blockade in gastrointestinal disease. Schlippert, W. Arch. Intern. Med. (1978) [Pubmed]
  5. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Stern, R.C., Eisenberg, J.D., Wagener, J.S., Ahrens, R., Rock, M., doPico, G., Orenstein, D.M. Am. J. Gastroenterol. (2000) [Pubmed]
  6. Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. Onodera, T., Toniolo, A., Ray, U.R., Jenson, A.B., Knazek, R.A., Notkins, A.L. J. Exp. Med. (1981) [Pubmed]
  7. Colipase and maximally activated pancreatic lipase in normal subjects and patients with steatorrhea. Gaskin, K.J., Durie, P.R., Hill, R.E., Lee, L.M., Forstner, G.G. J. Clin. Invest. (1982) [Pubmed]
  8. Effects of neomycin on absorption, synthesis, and/or flux of cholesterol in man. Sedaghat, A., Samuel, P., Crouse, J.R., Ahrens, E.H. J. Clin. Invest. (1975) [Pubmed]
  9. Lipolytic activity of bacterial lipase survives better than that of porcine lipase in human gastric and duodenal content. Raimondo, M., DiMagno, E.P. Gastroenterology (1994) [Pubmed]
  10. Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Heise, C., Dandekar, S., Kumar, P., Duplantier, R., Donovan, R.M., Halsted, C.H. Gastroenterology (1991) [Pubmed]
  11. Bile salt malabsorption in pancreatic insufficiency secondary to alcoholic pancreatitis. Dutta, S.K., Anand, K., Gadacz, T.R. Gastroenterology (1986) [Pubmed]
  12. Triolein breath test: a sensitive and specific test for fat malabsorption. Newcomer, A.D., Hofmann, A.F., DiMagno, E.P., Thomas, P.J., Carlson, G.L. Gastroenterology (1979) [Pubmed]
  13. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Reyes, H., Radrigan, M.E., Gonzalez, M.C., Latorre, R., Ribalta, J., Segovia, N., Alvarez, C., Andresen, M., Figueroa, D., Lorca, B. Gastroenterology (1987) [Pubmed]
  14. Deficiency of fat soluble vitamins after jejunoileal bypass surgery for morbid obesity. Rogers, E.L., Douglass, W., Russell, R.M., Bushman, L., Hubbard, T.B., Iber, F.L. Am. J. Clin. Nutr. (1980) [Pubmed]
  15. Assessment of intestinal and cardiorespiratory function in children with congenital heart disease on high-caloric formulas. Yahav, J., Avigad, S., Frand, M., Shem-Tov, A., Barzilay, Z., Linn, S., Jonas, A. J. Pediatr. Gastroenterol. Nutr. (1985) [Pubmed]
  16. Bioavailability of digoxin tablets in patients with gastrointestinal dysfunction. Gerson, C.D., Lowe, E.H., Lindenbaum, J. Am. J. Med. (1980) [Pubmed]
  17. Esophageal impairment in adult celiac disease with steatorrhea. Iovino, P., Ciacci, C., Sabbatini, F., Acioli, D.M., D'Argenio, G., Mazzacca, G. Am. J. Gastroenterol. (1998) [Pubmed]
  18. Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis. Groman, J.D., Karczeski, B., Sheridan, M., Robinson, T.E., Fallin, M.D., Cutting, G.R. J. Pediatr. (2005) [Pubmed]
  19. Sterol balance in abetalipoproteinemia: studies in a patient with homozygous familial hypobetalipoproteinemia. Illingworth, D.R., Connor, W.E., Buist, N.R., Jhaveri, B.M., Lin, D.S., McMurry, M.P. Metab. Clin. Exp. (1979) [Pubmed]
  20. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. Dawson, P.A., Haywood, J., Craddock, A.L., Wilson, M., Tietjen, M., Kluckman, K., Maeda, N., Parks, J.S. J. Biol. Chem. (2003) [Pubmed]
  21. Phenotype analysis of aquaporin-8 null mice. Yang, B., Song, Y., Zhao, D., Verkman, A.S. Am. J. Physiol., Cell Physiol. (2005) [Pubmed]
  22. Plasma concentrations of cholecystokinin and neurotensin in patients with cystic fibrosis. Herzig, K.H., Domagk, J., Nustede, R., Stern, M., Bewig, B., Cichy, W.K., Fölsch, U.R. Scand. J. Gastroenterol. (1997) [Pubmed]
  23. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction. Durie, P.R., Largman, C., Brodrick, J.W., Johnson, J.H., Gaskin, K.J., Forstner, G.G., Geokas, M.C. Pediatr. Res. (1981) [Pubmed]
  24. Somatostatinomas, PPomas, neurotensinomas. Vinik, A.I., Strodel, W.E., Eckhauser, F.E., Moattari, A.R., Lloyd, R. Semin. Oncol. (1987) [Pubmed]
  25. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea. Lembcke, B., Grimm, K., Lankisch, P.G. Am. J. Gastroenterol. (1987) [Pubmed]
  26. Serum cathodic trypsin-like immunoreactivity, pancreatic lipase, and pancreatic isoamylase as diagnostic tests of chronic pancreatitis or pancreatic steatorrhea. Møller-Petersen, J., Pedersen, J.O., Pedersen, N.T., Andersen, B.N. Scand. J. Gastroenterol. (1988) [Pubmed]
  27. What to do when a patient with exocrine pancreatic insufficiency does not respond to pancreatic enzyme substitution, a practical guide. Lankisch, P.G. Digestion (1999) [Pubmed]
  28. Symposium on diarrhea. 3. Investigation of chronic diarrhea. Groll, A. Canadian Medical Association journal. (1977) [Pubmed]
 
WikiGenes - Universities